Ubs Group Ag Inogen Inc Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Inogen Inc stock. As of the latest transaction made, Ubs Group Ag holds 51,509 shares of INGN stock, worth $434,220. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,509

Previous 56,622 9.03%

Holding current value

$434,220

Previous $460,000 8.48%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.67 - $12.98 $39,216 - $66,366	-5,113 Reduced 9.03%	51,509 $499,000
Q2 2024 Aug 13, 2024	BUY	$6.3 - $8.95 $220,878 - $313,787	35,060 Added 162.6%	56,622 $460,000
Q1 2024 May 13, 2024	SELL	$5.26 - $10.15 $1,209 - $2,334	-230 Reduced 1.06%	21,562 $174,000
Q4 2023 Feb 09, 2024	BUY	$4.21 - $6.32 $30,168 - $45,289	7,166 Added 48.99%	21,792 $119,000
Q3 2023 Nov 09, 2023	BUY	$5.14 - $11.28 $10,752 - $23,597	2,092 Added 16.69%	14,626 $76,000
Q2 2023 Aug 11, 2023	BUY	$10.01 - $13.86 $24,574 - $34,026	2,455 Added 24.36%	12,534 $144,000
Q1 2023 May 12, 2023	BUY	$11.88 - $26.0 $9,123 - $19,968	768 Added 8.25%	10,079 $125,000
Q4 2022 Feb 08, 2023	BUY	$19.14 - $24.55 $57,592 - $73,870	3,009 Added 47.75%	9,311 $183,000
Q3 2022 Nov 10, 2022	BUY	$22.74 - $31.8 $139,077 - $194,488	6,116 Added 3288.17%	6,302 $154,000
Q2 2022 Aug 10, 2022	SELL	$22.88 - $35.28 $60,082 - $92,645	-2,626 Reduced 93.39%	186 $5,000
Q1 2022 May 16, 2022	SELL	$28.1 - $35.25 $94,219 - $118,193	-3,353 Reduced 54.39%	2,812 $91,000
Q4 2021 Feb 14, 2022	BUY	$29.66 - $44.0 $169,506 - $251,460	5,715 Added 1270.0%	6,165 $209,000
Q3 2021 Nov 15, 2021	SELL	$43.09 - $82.26 $811,815 - $1.55 Million	-18,840 Reduced 97.67%	450 $19,000
Q2 2021 Aug 13, 2021	BUY	$52.03 - $68.77 $426,802 - $564,120	8,203 Added 73.99%	19,290 $1.26 Million
Q1 2021 May 12, 2021	SELL	$43.96 - $55.99 $1.02 Million - $1.29 Million	-23,100 Reduced 67.57%	11,087 $582,000
Q4 2020 Feb 11, 2021	BUY	$27.19 - $44.68 $117,623 - $193,285	4,326 Added 14.49%	34,187 $1.53 Million
Q3 2020 Nov 12, 2020	SELL	$27.01 - $37.31 $245,980 - $339,782	-9,107 Reduced 23.37%	29,861 $866,000
Q2 2020 Jul 31, 2020	BUY	$32.85 - $53.77 $793,031 - $1.3 Million	24,141 Added 162.82%	38,968 $1.38 Million
Q1 2020 May 01, 2020	SELL	$32.63 - $67.59 $403,176 - $835,142	-12,356 Reduced 45.45%	14,827 $766,000
Q4 2019 Feb 14, 2020	SELL	$45.95 - $76.15 $153,197 - $253,884	-3,334 Reduced 10.93%	27,183 $1.86 Million
Q3 2019 Nov 14, 2019	BUY	$41.82 - $66.71 $505,311 - $806,056	12,083 Added 65.55%	30,517 $1.46 Million
Q2 2019 Aug 14, 2019	SELL	$63.19 - $95.15 $324,101 - $488,024	-5,129 Reduced 21.77%	18,434 $1.23 Million
Q1 2019 May 14, 2019	SELL	$90.12 - $152.23 $4.38 Million - $7.4 Million	-48,618 Reduced 67.36%	23,563 $2.25 Million
Q4 2018 Feb 14, 2019	BUY	$112.83 - $239.74 $4.75 Million - $10.1 Million	42,110 Added 140.04%	72,181 $8.96 Million
Q3 2018 Nov 14, 2018	BUY	$189.1 - $282.92 $2.7 Million - $4.03 Million	14,258 Added 90.17%	30,071 $7.34 Million
Q2 2018 Aug 14, 2018	SELL	$123.8 - $192.48 $397,893 - $618,630	-3,214 Reduced 16.89%	15,813 $2.95 Million
Q1 2018 May 15, 2018	SELL	$114.22 - $133.22 $138,091 - $161,062	-1,209 Reduced 5.97%	19,027 $2.34 Million
Q4 2017 Feb 14, 2018	BUY	$93.4 - $128.74 $553,862 - $763,428	5,930 Added 41.45%	20,236 $2.41 Million
Q3 2017 Nov 14, 2017	SELL	$91.08 - $104.49 $18,398 - $21,106	-202 Reduced 1.39%	14,306 $1.36 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,072 Added 7.98%	14,508 $1.38 Million
Q1 2017 Nov 14, 2017	BUY	N/A	13,436	13,436 $1.04 Million

Others Institutions Holding INGN

# of Institutions

143

Shares Held

21M

Call Options Held

119K

Put Options Held

149K

View Full List

About Inogen Inc

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $193M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

More about INGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account